• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

R.E.N.A.L.肾计量评分可预测接受根治性肾切除术治疗的局限性肾细胞癌的术后复发情况。

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy.

作者信息

Nagahara Akira, Uemura Motohide, Kawashima Atsunari, Ujike Takeshi, Fujita Kazutoshi, Miyagawa Yasushi, Nonomura Norio

机构信息

Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

出版信息

Int J Clin Oncol. 2016 Apr;21(2):367-372. doi: 10.1007/s10147-015-0879-3. Epub 2015 Jul 29.

DOI:10.1007/s10147-015-0879-3
PMID:26219992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4824801/
Abstract

BACKGROUND

We investigated the association between the R.E.N.A.L. nephrometry score (RNS) and the postoperative recurrence of localized renal cell carcinoma (RCC).

METHODS

We retrospectively analyzed a database comprising 91 patients with non-small localized RCC (pT1b-T2b) treated by radical nephrectomy at our hospital from January 2002 to March 2010. RNS was scored based on imaging findings at diagnosis. The Cox proportional hazards model was used to predict recurrence-free survival (RFS) and to calculate hazard ratio (HR).

RESULTS

The median age at operation was 63 years (range, 30-85 years). Postoperative recurrence occurred in 19 patients (21 %). Median RNS sum was 9 (range, 5-11). High RNS sum (10-12) was significantly associated with RFS (P = 0.0012). Multivariate analysis revealed that high RNS sum [HR, 9.05; 95 % confidence interval (CI), 2.11-63.9; P = 0.0019] were significantly associated with RFS. Regarding each component of RNS, only the L component, which referred to tumor location relative to the polar line, was associated with RFS (HR, 15.0; 95 % CI, 2.68-396; P = 0.0006).

CONCLUSIONS

RNS was associated with RFS in cases of non-small localized RCC (pT1b-2b), thus supporting its utility as a prognostic factor.

摘要

背景

我们研究了R.E.N.A.L.肾计量评分(RNS)与局限性肾细胞癌(RCC)术后复发之间的关联。

方法

我们回顾性分析了一个数据库,该数据库包含2002年1月至2010年3月在我院接受根治性肾切除术治疗的91例非小局限性RCC(pT1b - T2b)患者。RNS根据诊断时的影像学表现进行评分。采用Cox比例风险模型预测无复发生存期(RFS)并计算风险比(HR)。

结果

手术时的中位年龄为63岁(范围30 - 85岁)。19例患者(21%)出现术后复发。RNS总和的中位数为9(范围5 - 11)。高RNS总和(10 - 12)与RFS显著相关(P = 0.0012)。多变量分析显示,高RNS总和[HR,9.05;95%置信区间(CI),2.11 - 63.9;P = 0.0019]与RFS显著相关。关于RNS的各个组成部分,只有L部分(指肿瘤相对于极线的位置)与RFS相关(HR,15.0;95%CI,2.68 - 396;P = 0.0006)。

结论

在非小局限性RCC(pT1b - 2b)病例中,RNS与RFS相关,因此支持其作为预后因素的效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c1/4824801/c51a8174e8a0/10147_2015_879_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c1/4824801/b34bac122e4a/10147_2015_879_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c1/4824801/c51a8174e8a0/10147_2015_879_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c1/4824801/b34bac122e4a/10147_2015_879_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69c1/4824801/c51a8174e8a0/10147_2015_879_Fig2_HTML.jpg

相似文献

1
R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy.R.E.N.A.L.肾计量评分可预测接受根治性肾切除术治疗的局限性肾细胞癌的术后复发情况。
Int J Clin Oncol. 2016 Apr;21(2):367-372. doi: 10.1007/s10147-015-0879-3. Epub 2015 Jul 29.
2
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).肾细胞癌肾切除术后 5 年以上复发相关特征:基于大型多中心数据库(CORONA/SATURN 项目)开发和内部验证预测晚期复发的风险模型(PRELANE 评分)。
Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22.
3
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.行肾切除术治疗 pT1 透明细胞肾细胞癌患者的三维肿瘤体积与癌症特异性生存。
BJU Int. 2012 Oct;110(7):956-60. doi: 10.1111/j.1464-410X.2012.10937.x. Epub 2012 Feb 2.
4
High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.高R.E.N.A.L.肾计量评分与根治性肾切除标本中临床T1期肾细胞癌的病理分期上调相关:对保留肾单位手术的意义。
J Endourol. 2014 Sep;28(9):1138-42. doi: 10.1089/end.2014.0123. Epub 2014 Jun 24.
5
R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.R.E.N.A.L.(半径、外生性/内生性、与集合系统或肾窦的接近程度、前后位以及相对于极线的位置)肾计量评分可预测肾细胞癌经皮消融治疗后的早期肿瘤复发和并发症:5年经验
J Vasc Interv Radiol. 2015 May;26(5):686-93. doi: 10.1016/j.jvir.2015.01.008. Epub 2015 Mar 11.
6
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.肾细胞癌局限性肾切除术后晚期复发的结局和临床病理变量。
Urology. 2011 Nov;78(5):1101-6. doi: 10.1016/j.urology.2011.05.012. Epub 2011 Sep 8.
7
How can the R.E.N.A.L. nephrometry scoring system aid management of a solid renal mass?R.E.N.A.L. 肾脏肿瘤评分系统如何帮助管理肾脏实性肿块?
Hong Kong Med J. 2014 Feb;20(1):37-44. doi: 10.12809/hkmj133920. Epub 2013 Jul 22.
8
Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.在实施部分肾切除术的时代,肾细胞癌的组织学亚型对生存率有显著影响。
Urol Oncol. 2016 Jun;34(6):259.e1-8. doi: 10.1016/j.urolonc.2016.01.005. Epub 2016 Mar 2.
9
Are urologists and radiologists equally effective in determining the RENAL Nephrometry score?泌尿外科医生和放射科医生在确定RENAL肾计量评分方面的效果一样吗?
Ann Surg Oncol. 2015 May;22(5):1618-24. doi: 10.1245/s10434-014-4152-1. Epub 2014 Nov 11.
10
Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.机器人辅助部分肾切除术治疗后临床 T1 到病理 T3a 肿瘤升级的结果和预测因素:多机构分析。
J Urol. 2013 Nov;190(5):1907-11. doi: 10.1016/j.juro.2013.06.014. Epub 2013 Jun 11.

引用本文的文献

1
Nephrometry scores to predict oncological outcomes following partial nephrectomy (UroCCR Study 70).肾部分切除术(UroCCR 研究 70)后预测肿瘤学结果的肾切除术评分。
World J Urol. 2023 Dec;41(12):3559-3566. doi: 10.1007/s00345-023-04633-3. Epub 2023 Oct 4.
2
Imaging Tool for Predicting Renal Clear Cell Carcinoma Fuhrman Grade: Comparing R.E.N.A.L. Nephrometry Score and CT Texture Analysis.预测肾透明细胞癌 Fuhrman 分级的影像学工具:比较 R.E.N.A.L. 肾肿瘤评分和 CT 纹理分析。
Biomed Res Int. 2021 Dec 23;2021:1821876. doi: 10.1155/2021/1821876. eCollection 2021.
3
Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China.

本文引用的文献

1
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.细胞周期蛋白依赖性激酶1(CDK1)和细胞周期蛋白依赖性激酶2(CDK2)的活性是肾细胞癌复发的有力预测指标。
Urol Oncol. 2014 Nov;32(8):1240-6. doi: 10.1016/j.urolonc.2014.05.006. Epub 2014 Nov 14.
2
Significant impact of R.E.N.A.L. nephrometry score on changes in postoperative renal function early after robot-assisted partial nephrectomy.R.E.N.A.L.肾测量评分对机器人辅助部分肾切除术后早期肾功能变化的显著影响。
Int J Clin Oncol. 2015 Jun;20(3):586-92. doi: 10.1007/s10147-014-0751-x. Epub 2014 Sep 17.
3
Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma.
成人 Xp11.2 易位肾细胞癌临床 T1 期行保留肾单位手术:中国多中心研究。
Ann Surg Oncol. 2021 Feb;28(2):1238-1246. doi: 10.1245/s10434-020-08813-y. Epub 2020 Jul 6.
4
Evaluation of the Clinical Use of Robot-Assisted Retroperitoneal Laparoscopy and Preoperative RENAL Scoring for Nephron Sparing Surgery in Renal Tumor Patients.机器人辅助腹膜后腹腔镜手术及术前RENAL评分在肾肿瘤患者保留肾单位手术中的临床应用评估
Indian J Surg. 2018 Jun;80(3):252-258. doi: 10.1007/s12262-016-1572-0. Epub 2016 Dec 26.
5
Role of R.E.N.A.L. Nephrometry Score in Laparoscopic Partial Nephrectomy.R.E.N.A.L. 肾脏解剖评分在腹腔镜部分肾切除术的作用。
Chin Med J (Engl). 2017 Sep 20;130(18):2170-2175. doi: 10.4103/0366-6999.213973.
6
Obesity as defined by waist circumference but not body mass index is associated with higher renal mass complexity.根据腰围而非体重指数定义的肥胖与更高的肾脏质量复杂性相关。
Urol Oncol. 2017 Nov;35(11):661.e1-661.e6. doi: 10.1016/j.urolonc.2017.06.058. Epub 2017 Aug 7.
血管内皮生长因子的血清水平及免疫组化表达对肾细胞癌术后复发的预测作用
BMC Res Notes. 2014 Jun 17;7:369. doi: 10.1186/1756-0500-7-369.
4
RENAL nephrometry score is a predictive factor for the annual growth rate of renal mass.肾脏肾计量评分是肾实质年生长率的一个预测因素。
Int J Urol. 2014 Jun;21(6):549-52. doi: 10.1111/iju.12388. Epub 2014 Jan 9.
5
Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score.R.E.N.A.L. 肾脏肿瘤评分分类的临床 T2 肾肿瘤行根治性和部分肾切除术的生存结果。
BJU Int. 2014 Nov;114(5):708-18. doi: 10.1111/bju.12580. Epub 2014 Oct 3.
6
Tumor complexity predicts malignant disease for small renal masses.肿瘤复杂性可预测小肾肿瘤的恶性疾病。
J Urol. 2012 Dec;188(6):2072-6. doi: 10.1016/j.juro.2012.08.027. Epub 2012 Oct 18.
7
External validation of the RENAL nephrometry score in renal tumours treated by partial nephrectomy.经部分肾切除术治疗的肾肿瘤中 RENAL 评分的外部验证。
BJU Int. 2013 Feb;111(2):233-9. doi: 10.1111/j.1464-410X.2012.11339.x. Epub 2012 Jul 12.
8
Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score.微创部分肾切除术围手术期结局预测:R.E.N.A.L 肾肿瘤评分的作用。
World J Urol. 2013 Oct;31(5):1183-9. doi: 10.1007/s00345-012-0876-3. Epub 2012 Apr 28.
9
Correlation of the RENAL nephrometry score with warm ischemia time after robotic partial nephrectomy.机器人辅助部分肾切除术热缺血时间与肾肿瘤分数的相关性。
World J Urol. 2013 Oct;31(5):1165-9. doi: 10.1007/s00345-012-0867-4. Epub 2012 Apr 19.
10
Renal lesions with low R.E.N.A.L nephrometry score are associated with more indolent renal cell carcinomas (RCCs) or benign histology: findings in an Australian cohort.肾肿瘤 R.E.N.A.L 评分低与惰性肾细胞癌(RCC)或良性组织学相关:澳大利亚队列研究结果。
BJU Int. 2012 Apr;109 Suppl 3:44-7. doi: 10.1111/j.1464-410X.2012.11046.x.